FI945781A0 - Nya steroider med pregnanstam, dessa innehållande farmaceutiska kompositioner och förfarande för framställning av dem - Google Patents
Nya steroider med pregnanstam, dessa innehållande farmaceutiska kompositioner och förfarande för framställning av demInfo
- Publication number
- FI945781A0 FI945781A0 FI945781A FI945781A FI945781A0 FI 945781 A0 FI945781 A0 FI 945781A0 FI 945781 A FI945781 A FI 945781A FI 945781 A FI945781 A FI 945781A FI 945781 A0 FI945781 A0 FI 945781A0
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- pharmaceutical compositions
- steroids
- compositions containing
- novel pregnane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/50—Three nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9201910A HU212308B (en) | 1992-06-09 | 1992-06-09 | Process for producing novel pregnane steroids and pharmaceutical compositions containing the same |
PCT/HU1993/000035 WO1993025570A1 (en) | 1992-06-09 | 1993-06-08 | Novel steroids with pregnane skeleton, pharmaceutical compositions containing them and process for preparing same |
Publications (2)
Publication Number | Publication Date |
---|---|
FI945781A FI945781A (sv) | 1994-12-08 |
FI945781A0 true FI945781A0 (sv) | 1994-12-08 |
Family
ID=10982020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI945781A FI945781A0 (sv) | 1992-06-09 | 1994-12-08 | Nya steroider med pregnanstam, dessa innehållande farmaceutiska kompositioner och förfarande för framställning av dem |
Country Status (17)
Country | Link |
---|---|
US (1) | US5547949A (sv) |
EP (1) | EP0646126A1 (sv) |
JP (1) | JPH07507792A (sv) |
KR (1) | KR950701933A (sv) |
AU (1) | AU4352393A (sv) |
CA (1) | CA2136546A1 (sv) |
CZ (1) | CZ308094A3 (sv) |
EE (1) | EE9400071A (sv) |
FI (1) | FI945781A0 (sv) |
HR (1) | HRP930956A2 (sv) |
HU (1) | HU212308B (sv) |
IL (1) | IL105943A0 (sv) |
NO (1) | NO944749L (sv) |
RU (1) | RU94046369A (sv) |
SI (1) | SI9300311A (sv) |
WO (1) | WO1993025570A1 (sv) |
ZA (1) | ZA934036B (sv) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2347027T3 (es) | 1998-05-22 | 2010-10-22 | The Board Of Trustees Of The Leland Stanford Junior University | Moleculas bifuncionales y terapias basadas en las mismas. |
US7081470B2 (en) * | 2001-01-31 | 2006-07-25 | H. Lundbeck A/S | Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
US20040127502A1 (en) * | 2001-01-31 | 2004-07-01 | Synaptic Pharmaceutical Corporation | Use of GAL3 antagonist for treatment of depression |
MY141867A (en) * | 2002-06-20 | 2010-07-16 | Vertex Pharma | Substituted pyrimidines useful as protein kinase inhibitors |
WO2006116718A2 (en) | 2005-04-28 | 2006-11-02 | Proteus Biomedical, Inc. | Pharma-informatics system |
US9062126B2 (en) | 2005-09-16 | 2015-06-23 | Raptor Pharmaceuticals Inc. | Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof |
NL2000323C2 (nl) * | 2005-12-20 | 2007-11-20 | Pfizer Ltd | Pyrimidine-derivaten. |
PL2805720T3 (pl) | 2008-05-28 | 2019-11-29 | Reveragen Biopharma Inc | Niehormonalne steroidowe modulatory nf-kb do leczenia choroby |
JP5564517B2 (ja) | 2009-02-20 | 2014-07-30 | ティーオー − ビービービー ホールディング ベスローテン フェンノートシャップ | グルタチオンをベースとする薬物送達システム |
CN102458374A (zh) | 2009-05-06 | 2012-05-16 | 实验室护肤股份有限公司 | 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法 |
US9198921B2 (en) | 2010-04-05 | 2015-12-01 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-κB for treatment of disease |
US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0263213B1 (en) * | 1986-10-09 | 1995-09-06 | The Upjohn Company | C20 Through C26 amino steroids |
US5099019A (en) * | 1985-09-12 | 1992-03-24 | Upjohn Company | Amines useful in producing pharmaceutically active CNS compounds |
FR2644789B1 (fr) * | 1989-03-22 | 1995-02-03 | Roussel Uclaf | Nouveaux steroides 19-nor, 3-ceto comportant une chaine en 17 aminosubstituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant |
FR2644787B1 (fr) * | 1989-03-22 | 1995-02-03 | Roussel Uclaf | Nouveaux steroides 21 aminosubstitues, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant |
JPH05503705A (ja) * | 1990-01-26 | 1993-06-17 | ジ・アップジョン・カンパニー | 5―酸素化―2,4,6―トリアミノピリミジン類 |
-
1992
- 1992-06-09 HU HU9201910A patent/HU212308B/hu not_active IP Right Cessation
-
1993
- 1993-06-08 EP EP93913455A patent/EP0646126A1/en not_active Withdrawn
- 1993-06-08 ZA ZA934036A patent/ZA934036B/xx unknown
- 1993-06-08 HR HRP930956AA patent/HRP930956A2/hr not_active Application Discontinuation
- 1993-06-08 US US08/351,448 patent/US5547949A/en not_active Expired - Fee Related
- 1993-06-08 CZ CZ943080A patent/CZ308094A3/cs unknown
- 1993-06-08 JP JP6501316A patent/JPH07507792A/ja active Pending
- 1993-06-08 AU AU43523/93A patent/AU4352393A/en not_active Abandoned
- 1993-06-08 IL IL105943A patent/IL105943A0/xx unknown
- 1993-06-08 KR KR1019940704496A patent/KR950701933A/ko not_active Application Discontinuation
- 1993-06-08 WO PCT/HU1993/000035 patent/WO1993025570A1/en not_active Application Discontinuation
- 1993-06-08 CA CA002136546A patent/CA2136546A1/en not_active Abandoned
- 1993-06-09 SI SI9300311A patent/SI9300311A/sl unknown
-
1994
- 1994-06-29 EE EE9400071A patent/EE9400071A/xx unknown
- 1994-12-06 RU RU94046369/04A patent/RU94046369A/ru unknown
- 1994-12-08 FI FI945781A patent/FI945781A0/sv not_active Application Discontinuation
- 1994-12-08 NO NO944749A patent/NO944749L/no unknown
Also Published As
Publication number | Publication date |
---|---|
FI945781A (sv) | 1994-12-08 |
JPH07507792A (ja) | 1995-08-31 |
KR950701933A (ko) | 1995-05-17 |
NO944749L (no) | 1995-02-08 |
EE9400071A (et) | 1995-12-15 |
IL105943A0 (en) | 1993-10-20 |
CZ308094A3 (en) | 1995-11-15 |
SI9300311A (sl) | 1993-12-31 |
HRP930956A2 (hr) | 1995-02-28 |
CA2136546A1 (en) | 1993-12-23 |
HUT64562A (en) | 1994-01-28 |
EP0646126A1 (en) | 1995-04-05 |
ZA934036B (en) | 1994-01-06 |
WO1993025570A1 (en) | 1993-12-23 |
HU9201910D0 (en) | 1992-09-28 |
RU94046369A (ru) | 1996-09-27 |
HU212308B (en) | 1996-05-28 |
US5547949A (en) | 1996-08-20 |
NO944749D0 (no) | 1994-12-08 |
AU4352393A (en) | 1994-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT72639A (en) | Substituted thiazolidinedione derivatives, pharmaceutical compositions containing them and process for their preparation | |
EE9700333A (et) | Substitueeritud 4-fenüülaminotiasoolid, nende valmistamise meetod ja neid sisaldavad farmakoloogilised kompositsioonid | |
IL116486A0 (en) | Novel piperidine derivatives processes for their preparation and pharmaceutical compositions containing them | |
HUT64734A (en) | Anthraquinone-derivativdes, process for preparing them and pharmaceutical compositions containing them | |
IL85741A0 (en) | Substituted 9-amino-tetrahydroacridines and related compounds,a process for their preparation and pharmaceutical compositions containing them | |
EP0470617A3 (en) | 17-substituted corticoid-17-alkylcarbonates, a process for their preparation and pharmaceutical compositions containing them | |
FI945781A0 (sv) | Nya steroider med pregnanstam, dessa innehållande farmaceutiska kompositioner och förfarande för framställning av dem | |
EE9400070A (et) | Bioloogiliselt aktiivsed eburnameniini derivaadid, neid sisaldavad farmatseutilised segud ja nende valmistamise protsess | |
FI960316A0 (sv) | Oxatiolaner, förfarande för deras framställning och farmaceutiska kompositioner innehållande desamma | |
HUT72319A (en) | Epoxy-succinic acid derivatives, pharmaceutical compositions containing them and process for their preparation | |
FI956278A0 (sv) | Substituerade 4-fenyltiazolderivat, förfarande för deras framställnin g och farmaceutiska kompositioner innehållande dem | |
ZA92299B (en) | Compounds having an aryltriazine structure,a process for their preparation,and pharmaceutical compositions comprising them | |
IL96366A0 (en) | Steroids,their manufacture and pharmaceutical compositions containing them | |
FI951561A0 (sv) | Nya 17 -substituerade 4-androstanderivat, farmaceutiska sammansättningar innehållande dessa samt förfarande för framställning av desamma | |
IL93477A0 (en) | Steroid derivatives,pharmaceutical compositions containing them and process for their preparation | |
AU6190594A (en) | New substituted benzodioxins, a process for their preparation and pharmaceutical compositions containing them | |
IL107994A0 (en) | Steroids process for their preparation and pharmaceutical compositions containing them | |
EP0418020A3 (en) | Cephalosporinderivatives, process for their preparation and pharmaceutical compositions | |
AU4756693A (en) | 1-heteroarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them | |
FI942675A0 (sv) | Nya substituerade oxazinoisokinolinderivat, farmaceutiska kompositioner innehållande dessa och förfarande för framställning av dessa | |
IL90219A0 (en) | Hydrazinocarbonyloxylabdanes,a process for their preparation and pharmaceutical compositions containing them | |
FI972129A (sv) | 6-metoxi-1H-bensotriazol-5-karboxamidderivat, förfarande för framställning av dessa och läkemedelskomposition innehållande densamma | |
AU672791B2 (en) | N-derivatives of (phenylethyl-beta-ol) amine, a process for their preparation and pharmaceutical compositions containing the same | |
GB9311927D0 (en) | Dihydropyridine derivatives,process for their preparation,pharmaceutical compositions containing same and the use thereof for a therapeutic purpose | |
AU3219693A (en) | New 1,4-dihydropyridine compounds, a process for their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |